Bristol Myers trades higher after the FDA approves an oral medication for schizophrenia in adults, fiscal fourth-quarter ...

Shorter-term technical measures like the stock’s 50-day and 200-day suggest that the stock’s current bullish momentum is ...

In a report released today, Rupesh Parikh from Oppenheimer maintained a Buy rating on Costco (COST – Research Report), with a price ...

Costco stock is lower Friday after the membership warehouse firm reported a top-line miss in its fiscal fourth quarter, but ...

Analyst Kelly Bania from BMO Capital reiterated a Buy rating on Costco (COST – Research Report) and increased the price target to $980.00 ...

These are the top stocks that gained the attention of retail traders and investors throughout the day: Alibaba Group Holding ...

Shares of NVIDIA remain in a long-term bullish trend with a target price of $150. Shares of Costco ( COST) are at the top of ...

Shares jumped 6% in premarket trading after the Food and Drug Administration approved a treatment for [schizophrenia patients]( ...

U.S. stocks traded higher this morning, with the Dow Jones index rising more than 100 points on Friday. Following the market ...

Costco ( COST) is slinging a lot of gold bars as prices for the yellow metal continue to surge. Sales of gold were up "double-digits" in the most recent quarter, Costco CFO Gary Millerchip told ...

The firm essentially argued that the stock is priced to perfection and that positive catalysts like its special dividend and ...